Ji Jiang - Publications

Affiliations: 
2000 North Carolina State University, Raleigh, NC 

74 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Zheng X, Wang W, Zhang Y, Ma Y, Zhao H, Gao H, Hu P, Jiang J. Development of an LC-MS/MS method for quantifying two main metabolites of abivertinib in human plasma. Biomedical Chromatography : Bmc. e4704. PMID 31629371 DOI: 10.1002/bmc.4704  0.6
2019 Liu J, Yao L, Zhang M, Jiang J, Yang M, Wang Y. Downregulation of LncRNA-XIST inhibited development of non-small cell lung cancer by activating miR-335/SOD2/ROS signal pathway mediated pyroptotic cell death. Aging. 11. PMID 31553952 DOI: 10.18632/aging.102291  0.76
2019 Li Y, Zhao Q, Hu P, Jiang J. CX1003 quantification by ultra-performance LC-MS/MS in human plasma and its application to a pharmacokinetic study in solid tumor patients. Bioanalysis. PMID 31478754 DOI: 10.4155/bio-2019-0096  0.6
2019 Cui C, Wang H, Wang Z, Jiang J, Wu N, Cui B, Zhang Q, Zhao Q, Hu P. An ultra HPLC-MS/MS method for quantification of hypidone hydrochloride (YL-0919) and application to a pharmacokinetic study. Bioanalysis. PMID 31397579 DOI: 10.4155/bio-2019-0111  0.6
2019 Wang H, Shao F, Liu X, Xu W, Ou N, Qin X, Liu F, Hou X, Hu H, Jiang J. Efficacy, safety and pharmacokinetics of ilaprazole infusion in healthy subjects and patients with esomeprazole as positive control. British Journal of Clinical Pharmacology. PMID 31332820 DOI: 10.1111/bcp.14076  0.44
2019 Yao X, Song L, Liu Y, Wang H, Liu J, Jiang J, Liu D, Hu P. Corrigendum to "A high-performance liquid chromatography-tandem mass spectrometry method for the analysis of lifirafenib, a novel RAF kinase and EGFR inhibitor, in human plasma and urine, and its application in a clinical pharmacokinetic study" [J. Pharm. Biomed. Anal. 166 (2019) 20-29]. Journal of Pharmaceutical and Biomedical Analysis. PMID 31255416 DOI: 10.1016/j.jpba.2019.04.047  0.76
2019 Zhuang Q, Pan R, Liu X, Xu W, Wang H, Zhang X, Lai X, Wang H, Zhang L, Jiang J. A validated ultra-HPLC-MS/MS method for determination of honokiol in human plasma and its application to a clinical pharmacokinetic study. Bioanalysis. 11: 1085-1098. PMID 31251102 DOI: 10.4155/bio-2019-0030  0.44
2019 Dong R, Wang H, Li D, Lang L, Gray F, Liu Y, Laffont CM, Young M, Jiang J, Liu Z, Learned SM. Pharmacokinetics of Sublingual Buprenorphine Tablets Following Single and Multiple Doses in Chinese Participants With and Without Opioid Use Disorder. Drugs in R&D. PMID 31197606 DOI: 10.1007/s40268-019-0277-9  0.44
2019 Yao X, Wu Y, Jiang J, Chen X, Liu D, Hu P. A population pharmacokinetic study to accelerate early phase clinical development for a novel drug, teriflunomide sodium, to treat systemic lupus erythematosus. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. PMID 31154006 DOI: 10.1016/j.ejps.2019.05.020  0.6
2019 Yao X, Wu Y, Jiang J, Hu P, Liu D, Chen X. Safety, Pharmacokinetics, and Pharmacogenetics of Single-Dose Teriflunomide Sodium and Leflunomide in Healthy Chinese Subjects. Clinical Drug Investigation. PMID 31016613 DOI: 10.1007/s40261-019-00786-5  0.6
2019 Wang S, Zheng X, Zhang Y, Hu P, Ding L, Mao L, Jiang J. Determination of BPI15086 and its metabolite in human plasma by ultra-high performance liquid chromatography-MS/MS and its application to a pharmacokinetic study. Bioanalysis. PMID 30994009 DOI: 10.4155/bio-2018-0307  0.6
2019 Zhou Y, Hu P, Huang Y, Sang N, Song K, Wang H, Wen J, Jiang J, Chen X. Corrigendum: Population Pharmacokinetic/Pharmacodynamic Model-Guided Dosing Optimization of a Novel Sedative HR7056 in Chinese Healthy Subjects. Frontiers in Pharmacology. 10: 251. PMID 30941039 DOI: 10.3389/fphar.2019.00251  0.6
2019 Zhuang Q, Liu X, Sun Z, Wang H, Jiang J. A validated UPLC-MS/MS method to determine free and total irinotecan and its two metabolites in human plasma after intravenous administration of irinotecan hydrochloride liposome injection. Journal of Pharmaceutical and Biomedical Analysis. 170: 112-123. PMID 30921645 DOI: 10.1016/j.jpba.2019.03.034  0.44
2018 Yao X, Song L, Liu Y, Wang H, Liu J, Jiang J, Liu D, Hu P. A high-performance liquid chromatography-tandem mass spectrometry method for the determination of lifrafenib, a novel RAF kinase and EGFR inhibitor, in human plasma and urine and its application in clinical pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis. 166: 20-29. PMID 30599278 DOI: 10.1016/j.jpba.2018.12.038  0.76
2018 Zhou Y, Wen J, Hu B, Wang H, Jiang J. Population Pharmacokinetic/Pharmacodynamic Model-Guided Dosing Optimization of a Novel Sedative HR7056 in Chinese Healthy Subjects. Frontiers in Pharmacology. 9: 1316. PMID 30510509 DOI: 10.3389/fphar.2018.01316  0.44
2018 Yao X, Liu Y, Song L, Jiang J, Xiao F, Liu D, Hu P. Development of a simple HPLC-MS/MS method to simultaneously determine teriflunomide and its metabolite in human plasma and urine: Application to clinical pharmacokinetic study of teriflunomide sodium and leflunomide. Biomedical Chromatography : Bmc. e4420. PMID 30362147 DOI: 10.1002/bmc.4420  0.6
2018 Cui C, Chen R, Jiang J, Liu R, Wang W, Zhao Q, Hu P. Simultaneous determination of FLZ and its metabolite (M1) in human plasma and urine by UHPLC-MS/MS: Application to a pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis. 164: 32-40. PMID 30342394 DOI: 10.1016/j.jpba.2018.10.018  0.6
2018 Zheng X, Cui X, Yu H, Jiang J. Development of a quantitative method for four photocyanine isomers using differential ion mobility and tandem mass spectrometry and its application in a preliminary pharmacokinetics investigation. Journal of Chromatography. A. PMID 30274691 DOI: 10.1016/j.chroma.2018.09.048  0.56
2018 Yang F, Jiang M, Lu M, Hu P, Wang H, Jiang J. Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphoma. Frontiers in Pharmacology. 9: 991. PMID 30210349 DOI: 10.3389/fphar.2018.00991  0.6
2018 Song L, Liu Y, Yao X, Liu H, Chen B, Ma X, Zhou H, Shih C, Jiang J, Chen X, Hu P, Liu D. Development of an HPLC-MS/MS method to determine janagliflozin in human plasma and urine: application in clinical study. Bioanalysis. PMID 30182735 DOI: 10.4155/bio-2018-0129  0.6
2018 Zheng X, Wang W, Zhang Y, Ma Y, Zhao H, Hu P, Jiang J. Development and validation of a UPLC-MS/MS method for quantification of osimertinib (AZD9291) and its metabolite AZ5104 in human plasma. Biomedical Chromatography : Bmc. e4365. PMID 30119142 DOI: 10.1002/bmc.4365  0.6
2018 Zhao Q, Liu H, Jiang J, Wu Y, Zhong W, Li L, Miya K, Abe M, Hu P. Non-Compartmental Pharmacokinetics and Safety of Single-Dose Eldecalcitol (ED-71) in Healthy Chinese Adult Males. Clinical Drug Investigation. PMID 30117129 DOI: 10.1007/s40261-018-0682-9  0.6
2018 Liu Y, Song L, Yao X, Wu Y, Liu H, Zhao Q, Jiang J, Shi C, Ma X, Zhou H, Liu D, Hu P. A high-performance liquid chromatography-tandem mass spectrometry method for simultaneous determination of imigliptin, its five metabolites and alogliptin in human plasma and urine and its application to a multiple-dose pharmacokinetic study. Biomedical Chromatography : Bmc. e4324. PMID 29952007 DOI: 10.1002/bmc.4324  0.6
2018 Liu X, Chen R, Zeng G, Gao Y, Liu X, Zhang D, Hu P, Wang H, Jiang J. Determination of a PDE4 inhibitor Hemay005 in human plasma and urine by UPLC-MS/MS and its application to a PK study. Bioanalysis. PMID 29863892 DOI: 10.4155/bio-2018-0004  0.6
2018 Liu Y, Yao X, Song L, Liu H, Zhao Q, Jiang J, Ni G, Shi C, Ma X, Zhou H, Liu D, Hu P. Metabolites characterization of a novel DPP-4 inhibitor, imigliptin in humans and rats using ultra-high performance liquid chromatography coupled with synapt high-resolution mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 157: 189-200. PMID 29803910 DOI: 10.1016/j.jpba.2018.05.029  0.6
2018 Liu X, Hu P, Wang Y, Wang X, Huang J, Li J, Li C, Wang H, Jiang J. A validated UPLC-MS/MS method for the quantitation of an unstable peptide, monocyte locomotion inhibitory factor (MLIF) in human plasma and its application to a pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis. 157: 75-83. PMID 29775810 DOI: 10.1016/j.jpba.2018.04.009  0.76
2018 Jiang J, Tam LM, Wang P, Wang Y. Arsenite Targets the RING Finger Domain of Rbx1 E3 Ubiquitin Ligase to Inhibit Proteasome-mediated Degradation of Nrf2. Chemical Research in Toxicology. PMID 29658272 DOI: 10.1021/acs.chemrestox.8b00062  0.76
2018 Ma Y, Zheng X, Zhao H, Fang W, Zhang Y, Ge J, Wang L, Wang W, Jiang J, Chuai S, Zhang Z, Xu W, Xu X, Hu P, Zhang L. First-in-Human Phase I Study of AC0010, a Mutant-Selective EGFR Inhibitor in Non-Small Cell Lung Cancer: Safety, Efficacy, and Potential Mechanism of Resistance. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 29626621 DOI: 10.1016/j.jtho.2018.03.025  0.6
2018 Song L, Zhang Y, Jiang J, Ren S, Chen L, Liu D, Chen X, Hu P. Development of a Physiologically Based Pharmacokinetic Model for Sinogliatin, a First-in-Class Glucokinase Activator, by Integrating Allometric Scaling, In Vitro to In Vivo Exploration and Steady-State Concentration-Mean Residence Time Methods: Mechanistic Understanding of its Pharmacokinetics. Clinical Pharmacokinetics. PMID 29626326 DOI: 10.1007/s40262-018-0631-z  0.6
2018 Cui C, Hu P, Jiang J, Kong F, Luo H, Zhao Q. An UPLC-MS/MS method to determine CT-707 and its two metabolites in plasma of ALK-positive advanced non-small cell lung cancer patients. Journal of Pharmaceutical and Biomedical Analysis. 153: 1-8. PMID 29455091 DOI: 10.1016/j.jpba.2018.01.042  0.6
2018 Chen X, Jiang J, Hu P, Zajic S, Liu W, McCrea J, Liu F, Witter R, Mangin E, Stoch SA. Odanacatib Pharmacokinetics Comparison Between Chinese and Non-Chinese Postmenopausal Women. Clinical Pharmacology in Drug Development. PMID 29443463 DOI: 10.1002/cpdd.434  0.6
2017 Liu Y, Shao S, Song H, Yao X, Liu J, Liu H, Song L, Jiang J, Liu D, Hu P. Simultaneous determination of TPN729 and its five metabolites in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 151: 91-105. PMID 29310052 DOI: 10.1016/j.jpba.2017.12.057  0.76
2017 Cui X, Zheng X, Jiang J, Tan F, Ding L, Hu P. Simultaneous determination of a novel c-Met/AXL dual-target small-molecule inhibitor BPI-9016M and its metabolites in human plasma by liquid chromatography-tandem mass spectrometry: Application in a pharmacokinetic study in Chinese advanced solid tumor patients. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1068: 33-40. PMID 29028616 DOI: 10.1016/j.jchromb.2017.10.017  0.6
2017 Tam LM, Jiang J, Wang P, Li L, Miao W, Dong X, Wang Y. Arsenite Binds to the Zinc Finger Motif of TIP60 Histone Acetyltransferase and Induces Its Degradation via the 26S Proteasome. Chemical Research in Toxicology. PMID 28837777 DOI: 10.1021/acs.chemrestox.7b00146  0.76
2017 Xu W, Zhuang Q, Chen X, Jiang J, Hu P, Wang H. Simultaneous determination of morphine-6-D-glucuronide, morphine-3-D-glucuronide and morphine in human plasma and urine by ultra-performance liquid chromatography-tandem mass spectrometry: application to M6G injection pharmacokinetic study. Biomedical Chromatography : Bmc. PMID 28833311 DOI: 10.1002/bmc.4066  0.6
2017 Chen X, Jiang J, Giri N, Hu P. Phase 1 study to investigate the pharmacokinetic properties of dacomitinib in healthy adult Chinese subjects genotyped for CYP2D6. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 1-29. PMID 28648122 DOI: 10.1080/00498254.2017.1342881  0.6
2017 Wang Z, Wang H, Hu P, Jiang J, Zhao Q. A UPLC-MS/MS method for quantification of 5α-androst-3β,5,6β-triol in human plasma: development, validation and its application in clinical pharmacokinetic study. Bioanalysis. PMID 28617033 DOI: 10.4155/bio-2017-0035  0.6
2017 Jiang J, Bellani M, Li L, Wang P, Seidman MM, Wang Y. Arsenite Binds to the RING Finger Domain of FANCL E3 Ubiquitin Ligase and Inhibits DNA Interstrand Cross-link Repair. Acs Chemical Biology. PMID 28535027 DOI: 10.1021/acschembio.6b01135  0.76
2017 Wang L, Zheng X, Wang W, Hu P, Jiang J. An LC-MS/MS method for quantification of AC0010, a novel mutant-selective epidermal growth factor receptor (EGFR) inhibitor, and its metabolites in human plasma and the application to a pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis. 141: 9-18. PMID 28414972 DOI: 10.1016/j.jpba.2017.03.051  0.6
2017 Wang W, Zheng X, Wang H, Wang L, Jiang J, Hu P. Development of an UPLC-MS/MS method for quantification of Avitinib (AC0010) and its five metabolites in human cerebrospinal fluid: Application to a study of the blood-brain barrier penetration rate of non-small cell lung cancer patients. Journal of Pharmaceutical and Biomedical Analysis. 139: 205-214. PMID 28285073 DOI: 10.1016/j.jpba.2017.02.057  0.6
2017 Zhou Y, Hu P, Jiang J. Metabolite characterization of a novel sedative drug, remimazolam in human plasma and urine using ultra high-performance liquid chromatography coupled with synapt high-definition mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 137: 78-83. PMID 28104560 DOI: 10.1016/j.jpba.2017.01.016  0.6
2017 Wang Z, Jiang J, Hu P, Zhao Q. Development and validation of a UPLC-MS/MS method for simultaneous determination of fotagliptin and its two major metabolites in human plasma and urine. Bioanalysis. PMID 28102710 DOI: 10.4155/bio-2016-0243  0.6
2017 Wang H, Liu H, Liu M, Wang W, Zhu L, Huang H, Hu P, Jiang J. Pharmacokinetics of LBPT and its primary metabolites, as well as tolerability in the first-in-human study. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. PMID 28057550 DOI: 10.1016/j.ejps.2016.12.038  0.6
2016 Chen X, Liu D, Wu Y, Liu Y, Song H, Jiang J, Hu P. A single and multiple postprandial dose study investigating the pharmacokinetics and pharmacodynamics of edoxaban in healthy Chinese volunteers
. International Journal of Clinical Pharmacology and Therapeutics. PMID 28025966 DOI: 10.5414/CP202737  0.6
2016 Liu D, Zhang Y, Jiang J, Choi J, Li X, Zhu D, Xiao D, Ding Y, Fan H, Chen L, Hu P. Translational Modeling and Simulation in Supporting Early-Phase Clinical Development of New Drug: A Learn-Research-Confirm Process. Clinical Pharmacokinetics. PMID 28000102 DOI: 10.1007/s40262-016-0484-2  0.6
2016 Wang Z, Zhao Q, Li L, Hu P, Dong K, Chen S, Jiang J. Development and validation of a rapid and sensitive UPLC-MS/MS method for quantification of kukoamine B in human plasma: Application to a clinical pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis. 132: 1-6. PMID 27693755 DOI: 10.1016/j.jpba.2016.09.032  0.36
2016 Xu X, Mao L, Xu W, Tang W, Zhang X, Xi B, Xu R, Fang X, Liu J, Fang C, Zhao L, Wang X, Jiang J, Hu P, Zhao H, et al. AC0010, an irreversible EGFR inhibitor selectively targeting mutated EGFR and overcoming T790M-induced resistance in animal models and lung cancer patients. Molecular Cancer Therapeutics. PMID 27573423 DOI: 10.1158/1535-7163.MCT-16-0281  0.76
2016 Chen X, Liu D, Wu Y, Song H, Liu Y, Jiang J, Hu P. A single-dose study investigating the pharmacokinetics and pharmacodynamics of edoxaban at 30-90 mg in healthy Chinese volunteers. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 1-8. PMID 27560456 DOI: 10.1080/00498254.2016.1207825  0.6
2016 Liu D, Song H, Song L, Liu Y, Cao Y, Jiang J, Hu P. A unified strategy in selection of the best allometric scaling methods to predict human clearance based on drug disposition pathway. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 1-7. PMID 27460758 DOI: 10.1080/00498254.2016.1205761  0.6
2016 Zhao Q, Chen X, Li J, Jiang J, Li M, Zhong W, Li Z, Leung SO, Zhang F, Hu P. Pharmacokinetics, Pharmacodynamics and Preliminary Observations for Clinical Activity and Safety of Multiple Doses of Human Mouse Chimeric Anti-CD22 Monoclonal Antibody (SM03) in Chinese Patients with Systemic Lupus Erythematosus. Clinical Drug Investigation. PMID 27424629 DOI: 10.1007/s40261-016-0426-7  0.32
2016 Cui X, Huang J, Zheng X, Jiang J, Kuang Y, Hu P. Simultaneous determination of roflumilast and its metabolite in human plasma by LC-MS/MS: Application for a pharmacokinetic study. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1029: 60-67. PMID 27423044 DOI: 10.1016/j.jchromb.2016.06.001  0.36
2016 Chen X, Zhao Q, Zhang J, Liu T, Jiang J, Hu P. An open-label, multiple-dose study to assess the pharmacokinetics and tolerability of sitagliptin/metformin fixed-dose combination (FDC) tablet in healthy Chinese adult subjects. International Journal of Clinical Pharmacology and Therapeutics. PMID 27390052 DOI: 10.5414/CP202646  0.6
2016 Liu D, Ma X, Liu Y, Zhou H, Shi C, Wu F, Jiang J, Hu P. Quantitative prediction of human pharmacokinetics and pharmacodynamics of imigliptin, a novel DPP-4 inhibitor, using allometric scaling, IVIVE and PK/PD modeling methods. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. PMID 27108678 DOI: 10.1016/j.ejps.2016.04.020  0.36
2016 Wang H, Lang L, Ou N, Shi R, Hu H, Hu P, Jiang J. Pharmacokinetics, Pharmacodynamics and Safety of Multiple-Infusion Ilaprazole in Healthy Chinese Subjects. Clinical Drug Investigation. PMID 27067231 DOI: 10.1007/s40261-016-0390-2  0.32
2016 Wang H, Ou N, Lang L, Shi R, Hu P, Jiang J. Pharmacokinetics and pharmacodynamics of intravenous ilaprazole in healthy subjects after single ascending doses. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 1-9. PMID 26998954 DOI: 10.3109/00498254.2016.1156185  0.32
2016 Liu D, Yang H, Jiang J, Nagy P, Shen K, Qian J, Hu P. Pharmacokinetic and Pharmacodynamic Modeling Analysis of Intravenous Esomeprazole in Healthy Volunteers. Journal of Clinical Pharmacology. PMID 26970404 DOI: 10.1002/jcph.733  0.6
2016 Chen X, Zhao Q, Jiang J, Liu J, Hu P. Pharmacokinetics of Rasagiline in Healthy Adult Chinese Volunteers with Various Genotypes: A Single-Center, Open-Label, Multiple-Dose Study. Clinical Drug Investigation. PMID 26951202 DOI: 10.1007/s40261-016-0380-4  0.32
2016 Chen X, Zhao Q, Hou Y, Jiang J, Zhong W, Wang W, Yao X, Li L, Fang J, Zhang F, Hu P. Pharmacokinetics, pharmacodynamics, short-term efficacy and safety of RCT-18, A Novel BLyS/APRIL fusion protein, in patients with rheumatoid arthritis. British Journal of Clinical Pharmacology. PMID 26917504 DOI: 10.1111/bcp.12908  0.36
2016 Liu H, Wang H, Liu T, Jiang J, Chen X, Gao F, Hu P. Pharmacokinetic and Pharmacodynamic Properties of Cinacalcet (KRN1493) in Chinese Healthy Volunteers: A Randomized, Open-Label, Single Ascending-Dose and Multiple-Dose, Parallel-Group Study. Clinical Therapeutics. PMID 26804640 DOI: 10.1016/j.clinthera.2015.12.015  0.32
2015 Zhao Q, Chen X, Hou Y, Jiang J, Zhong W, Yao X, Wang W, Li L, Fang J, Zhang F, Hu P. Pharmacokinetics, Pharmacodynamics, Safety and Clinical Activity of Multiple Doses of RCT-18 in Chinese Patients with Systemic Lupus Erythematosus. Journal of Clinical Pharmacology. PMID 26634642 DOI: 10.1002/jcph.686  0.6
2015 Wang HY, Chen X, Jiang J, Shi J, Hu P. Evaluating a physiologically based pharmacokinetic model for predicting the pharmacokinetics of midazolam in Chinese after oral administration. Acta Pharmacologica Sinica. PMID 26592516 DOI: 10.1038/aps.2015.122  0.32
2015 Zhao Q, Wang BY, Jiang J, Hu P. [Quantification of sitagliptin in human plasma and urine by LC-MS/MS method and its application]. Yao Xue Xue Bao = Acta Pharmaceutica Sinica. 50: 714-8. PMID 26521442  0.6
2015 Zhao Q, Li P, Jiang J, Hu P. Pharmacokinetics of Single Ascending Doses and Multiple Doses of 20(S)-Ginsenoside Rg3 in Chinese Healthy Volunteers. European Journal of Drug Metabolism and Pharmacokinetics. PMID 26470874 DOI: 10.1007/s13318-015-0304-3  0.6
2015 Liu S, Jiang J, Li L, Amato NJ, Wang Z, Wang Y. Arsenite Targets the Zinc Finger Domains of Tet Proteins and Inhibits Tet-mediated Oxidation of 5-Methylcytosine. Environmental Science & Technology. PMID 26355596 DOI: 10.1021/acs.est.5b03386  0.76
2015 Liu Y, Liu D, Liu H, Song H, Song L, Yao X, Wu F, Shu C, Ma X, Zhou H, Jiang J, Hu P. Simultaneous determination of imigliptin and its three metabolites in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1002: 300-312. PMID 26355270 DOI: 10.1016/j.jchromb.2015.08.003  0.36
2015 Ni J, Liu DY, Hu B, Li C, Jiang J, Wang HP, Zhang L. Relationship between icotinib hydrochloride exposure and clinical outcome in Chinese patients with advanced non-small cell lung cancer. Cancer. 121: 3146-56. PMID 26331821 DOI: 10.1002/cncr.29568  0.36
2015 Zhao Q, Hu JP, Jiang J, Li Y, Hu P. [Interaction of butylphthalide with rat and human liver CYP450 isoenzymes]. Yao Xue Xue Bao = Acta Pharmaceutica Sinica. 50: 541-6. PMID 26234133  0.6
2015 Liu D, Zhang L, Wu Y, Jiang J, Tan F, Wang Y, Liu Y, Hu P. Clinical pharmacokinetics, safety, and preliminary efficacy evaluation of icotinib in patients with advanced non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). PMID 26162563 DOI: 10.1016/j.lungcan.2015.05.024  0.76
2015 Chen X, Zheng X, Jiang J, Hu P, Wu K, Zhuang L, Liu L, Du X, Kempsford R, Allen A. Pharmacodynamics and Pharmacokinetics of Fluticasone Furoate/Vilanterol in Healthy Chinese Subjects. Pharmacotherapy. 35: 586-99. PMID 26059225 DOI: 10.1002/phar.1598  0.36
2015 Hu P, Chen J, Liu D, Zheng X, Zhao Q, Jiang J. Development of population pharmacokinetics model of icotinib with non-linear absorption characters in healthy Chinese volunteers to assess the CYP2C19 polymorphism and food-intake effect. European Journal of Clinical Pharmacology. 71: 843-50. PMID 25995169 DOI: 10.1007/s00228-015-1864-5  0.6
2015 Chen J, Liu D, Zheng X, Zhao Q, Jiang J, Hu P. Relative contributions of the major human CYP450 to the metabolism of icotinib and its implication in prediction of drug-drug interaction between icotinib and CYP3A4 inhibitors/inducers using physiologically based pharmacokinetic modeling. Expert Opinion On Drug Metabolism & Toxicology. 11: 857-68. PMID 25850339 DOI: 10.1517/17425255.2015.1034688  0.6
2015 Chen X, Matsuzawa T, Hitsu E, Zhong W, Qian Z, Jiang J, Hu P. Modeling the dermatopharmacokinetic profile of two loxoprofen patches for bioequivalence confirmation. International Journal of Clinical Pharmacology and Therapeutics. 53: 412-3. PMID 25828640 DOI: 10.5414/CP202281  0.6
2015 Zhao Q, Jiang J, Hu P. Effects of four traditional Chinese medicines on the pharmacokinetics of simvastatin. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 1-8. PMID 25801058 DOI: 10.3109/00498254.2015.1019593  0.6
2015 Yang F, Wang H, Hu P, Jiang J. Validation of an UPLC-MS-MS Method for Quantitative Analysis of Vincristine in Human Urine After Intravenous Administration of Vincristine Sulfate Liposome Injection. Journal of Chromatographic Science. 53: 974-8. PMID 25520304 DOI: 10.1093/chromsci/bmu164  0.6
Show low-probability matches.